Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| IMCC | 6-K | mixed | 6/10 | IM Cannabis Corp. closed the sale of IMC Holdings and its European-focused operations to Slil.com Holding Ltd., a compan | Oct 2, 2026 |
| CURLF | 8-K | neutral | 2/10 | Curaleaf filed an 8-K announcing the timing of its Q3 2026 earnings release and conference call for November 3, 2026. No | Oct 1, 2026 |
| CURLF | 8-K | neutral | 3/10 | Curaleaf Holdings announced its addition to the FTSE Canada All Cap Index, effective September 18, 2026. This is the sec | Oct 1, 2026 |
| GTBIF | COURT-RULING | neutral | 2/10 | A federal district court denied Green Thumb's motion to dismiss an employment discrimination lawsuit brought by a former | Sep 28, 2026 |
| IMCC | 6-K | bearish | 6/10 | IM Cannabis Corp. closed a registered direct offering of 655,000 common shares at $2.00/share, raising $1.31 million in | Sep 25, 2026 |
| CGC | DEFA14A | neutral | 3/10 | Canopy Growth's 2026 Annual General and Special Meeting was convened and adjourned due to lack of quorum (33 1/3% of out | Sep 25, 2026 |
| TLRY | PRESS-RELEASE | neutral | 1/10 | Tilray Brands, Inc. announced it will report its fiscal Q1 2027 results on October 8, 2026. | Sep 25, 2026 |
| IMCC | 424B5 | bearish | 7/10 | IM Cannabis Corp. is conducting a registered direct offering of 655,000 common shares at US$2.00 per share, raising appr | Sep 24, 2026 |
| IMCC | 6-K | bearish | 6/10 | IM Cannabis Corp. (IMCC) has entered into securities purchase agreements to sell 655,000 common shares at $2.00 per shar | Sep 24, 2026 |
| IMCC | 6-K | mixed | 6/10 | IM Cannabis Corp. (IMCC) announced a non-binding LOI to acquire 51% of Space Defense Innovations LLC (SDI), a Polish UAS | Sep 23, 2026 |
| VFF | CLUSTER | bullish | 5/10 | CEO Michael DeGiglio purchased $101K of VFF stock in an open-market buy, joined by Director Christopher Woodward with a | Sep 22, 2026 |
| GCAN | 8-K | neutral | 2/10 | Trafalgar International CEO Porfirio Sanchez Talavera resigned effective September 18, 2026, and was immediately replace | Sep 21, 2026 |
| GRWG | CLUSTER | neutral | 3/10 | GrowGeneration Corp. CEO Darren Lampert and Director Eula Adams made open-market purchases totaling $106K (0.03% of mark | Sep 18, 2026 |
| CURLF | 8-K | neutral | 3/10 | Curaleaf Holdings filed an 8-K with Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits), but no docum | Sep 16, 2026 |
| CURLF | 425 | bullish | 6/10 | Curaleaf published a brochure directly appealing to Aurora shareholders to tender their shares to its hostile takeover b | Sep 16, 2026 |
| ACB | 6-K | neutral | 4/10 | Aurora Cannabis issued a business update reaffirming FY27 Q2 guidance for sequential growth in net revenue and adjusted | Sep 16, 2026 |
| CURLF | 425, 8-K | neutral | 3/10 | Curaleaf Holdings filed an 8-K with Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits), but the docu | Sep 15, 2026 |
| CGC | DEFA14A | neutral | 3/10 | Analysis based on filing metadata only — document content was unavailable. This is a DEFA14A proxy solicitation filing b | Sep 15, 2026 |
| ACB | 6-K | neutral | 5/10 | Aurora Cannabis refutes Curaleaf's application to halt its ATM program, calling it a distraction from Curaleaf's alleged | Sep 14, 2026 |
| VFF | 8-K | neutral | 3/10 | Village Farms appointed Hamid Shekarchi as Interim CFO, replacing Stephen Ruffini who transitions to Head of M&A and Cor | Sep 10, 2026 |
| ACB | 6-K | neutral | 3/10 | Aurora Cannabis announced the appointment of Faris El Refaie, a biopharmaceutical executive with 25 years of experience, | Sep 9, 2026 |
| OGI | 6-K | neutral | 3/10 | Organigram Global announced its second annual digital investor session scheduled for September 30, 2026. The event will | Sep 3, 2026 |
| CURLF | 425, 8-K | neutral | 4/10 | Curaleaf issued a press release responding to Aurora Cannabis' Directors' Circular, reiterating its hostile takeover off | Sep 2, 2026 |
| ACB | 6-K | bullish | 7/10 | Aurora Cannabis filed a 6-K urging shareholders to reject Curaleaf's hostile takeover bid, arguing it is inadequate and | Sep 2, 2026 |
| ACB | 6-K | neutral | 5/10 | Aurora Cannabis filed a 6-K responding to Curaleaf Holdings' hostile takeover bid, correcting what it calls inaccurate s | Aug 24, 2026 |
| OGI | 6-K | mixed | 6/10 | Organigram is accelerating the integration of Sanity Group, replacing the performance-based earnout with a fixed earnout | Aug 20, 2026 |
| ACB | 6-K | bullish | 5/10 | Aurora Cannabis acquired 100% of Internode Pharma Limited and HAP Pharma Limited for GBP 2.1 million in cash, gaining a | Aug 19, 2026 |
| ACB | PRESS-RELEASE | bullish | 5/10 | Aurora Cannabis acquired Internode Pharma Limited and HAP Pharma Limited for GBP 2.1 million in cash, gaining direct own | Aug 19, 2026 |
| ACB | 6-K | bullish | 7/10 | Aurora Cannabis confirms Curaleaf Holdings has launched an unsolicited take-over bid for all outstanding common shares a | Aug 19, 2026 |
| CGC | DEFA14A | neutral | 3/10 | Canopy Growth mailed proxy materials for its Sept 25, 2026 Annual General and Special Meeting, urging shareholders to vo | Aug 17, 2026 |